Features Pricing FAQ About Login Sign Up

Federal solicitation · ARPA-H-SN-26-158 · back to recent

Area of Interest under PHO ISO: ASCENT-IBO

HEALTH AND HUMAN SERVICES, DEPARTMENT OF · NAICS 541715 · Deadline 2026-10-15T17:00:00-04:00

View on SAM.gov →

Solicitation description

See attached Special Notice ARPA-H-SN-26-158: Accelerating Safe Clinical Evaluation of Novel Treatments: Ibogaine for Better outcomes in OUD (ASCENT-IBO) This Special Notice builds upon ARPA-H-SN-26-156 and includes details related to a Proposers’ Day event.

Vendor field in NAICS 541715 (12m)

Top 5 vendors by trailing-12m obligated dollars across this NAICS code, $3,164.9M total.

LOCKHEED MARTIN CORPORATION 16.2%
RAYTHEON COMPANY 15.4%
LEIDOS BIOMEDICAL RESEARCH INC 15.2%
THE MITRE CORPORATION 11.2%
NORTHROP GRUMMAN SYSTEMS CORPORATION 9.7%

Similar opportunities

Other open SAM.gov opportunities under the same NAICS, prioritizing the same buying agency.

Title Agency Est. value Basis
Evaluation and Conduct of Computational and Alternative... HEALTH AND HUMAN... $79.3M same agency naics
2026 NIAID DMID Omnibus Broad Agency Announcement HEALTH AND HUMAN... $23.9M same agency naics
Analytical Services Center for Medications Development Program HEALTH AND HUMAN... $5.0M same agency naics
Maximum Tolerated Dose (MTD) Evaluation of PIP4Kga HEALTH AND HUMAN... - same agency naics
Chip-S1 Basic Research Kits, Compound Distribution Kits,... HEALTH AND HUMAN... - same agency naics
Chemistry Support for the DTT HEALTH AND HUMAN... - same agency naics
Notice of Intent to Sole Source CAES Fall acaricide... HEALTH AND HUMAN... - same agency naics
Notice of Intent to Sole Source - Sister Study PFAS and... HEALTH AND HUMAN... - same agency naics

Data this profile does NOT cover

  • No likely incumbent surfaced; the solicitation number did not prefix-match any award in the FPDSAward window.